27 CPZ-induced MDR3 inhibition could prevent phospholipids translocation and formation of biliary micelles with BA and could represent another potential mechanism for drug-induced intrahepatic cholestasis. However, little is known about inhibition of MDR3 by cholestatic drugs, with the exception of a recent study showing the involvement of MDR3 in itraconazole-induced cholestasis.28 If alterations of some transporters appeared to contribute to cholestasis, changes of
several others rather represent compensatory mechanisms, which provide alternative excretory routes for accumulated BA in cholestasis.29 As such, expression of the basolateral BA uptake transporter NTCP was down-regulated, whereas that of the alternative basolateral BA export transporter MRP4 was enhanced after 24-hour check details CPZ exposure of HepaRG cells. NTCP down-regulation and MRP4 up-regulation likely represented a protective Y-27632 in vitro response against CPZ-induced cholestasis. Indeed, several studies have reported a reduction of NTCP expression in human and rodent liver cholestasis30-32 as well as an inhibition of CYP8B1 that is involved in
the synthesis of cholic acid.29 Accordingly, CPZ showed a decrease of CYP8B1 expression in our study. Overexpression of CYP3A4 usually represents an additional adaptive mechanism facilitating elimination of BA.29 CYP3A4 induction was observed independently of the oxidative stress after 24-hour treatment with low CPZ concentrations, contrary to other compensatory mechanisms.
However, CYP3A4 expression was down-regulated by high concentrations of BA, H2O2, and 48-hour CPZ exposure. Such CYP3A4 inhibition could be related to a toxic effect and/or an inflammatory response. A ROS-dependent selleck chemicals llc hepatic inflammatory response has indeed been proposed to explain at least part of the transcriptional alterations occurring in cholestasis.6 Accordingly, CPZ induced expression of the proinflammatory cytokines interleukin (IL)-1β, IL-6, and IL-8 in HepaRG cells (data not shown). IL-1β has been previously found to impair expression of membrane transporters, especially BSEP, in HepaRG cells.33 Undoubtedly, liver cell models have certain limitations for investigating drug-induced idiosyncratic hepatotoxicity, especially due to the absence of immune and other liver cells. Therefore, coculturing HepaRG cells with immune or inflammatory cells should still improve their suitability for investigating idiosyncratic hepatotoxicity of certain drugs. To compare CPZ-induced cholestasis to cholestasis-like condition caused by BA overload, HepaRG cells were overloaded with two BA, cholic and chenodeoxycholic acids, for 24 hours. This BA overload resulted in the induction of two concentration-dependent responses.